These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 32761725
1. NIR-Absorbing RuII Complexes Containing α-Oligothiophenes for Applications in Photodynamic Therapy. Lifshits LM, Roque JA, Cole HD, Thummel RP, Cameron CG, McFarland SA. Chembiochem; 2020 Dec 11; 21(24):3594-3607. PubMed ID: 32761725 [Abstract] [Full Text] [Related]
2. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy. Wang L, Yin H, Jabed MA, Hetu M, Wang C, Monro S, Zhu X, Kilina S, McFarland SA, Sun W. Inorg Chem; 2017 Mar 20; 56(6):3245-3259. PubMed ID: 28263079 [Abstract] [Full Text] [Related]
4. Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy. Roque JA, Barrett PC, Cole HD, Lifshits LM, Bradner E, Shi G, von Dohlen D, Kim S, Russo N, Deep G, Cameron CG, Alberto ME, McFarland SA. Inorg Chem; 2020 Nov 16; 59(22):16341-16360. PubMed ID: 33126792 [Abstract] [Full Text] [Related]
5. Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents. Cole HD, Vali A, Roque JA, Shi G, Kaur G, Hodges RO, Francés-Monerris A, Alberto ME, Cameron CG, McFarland SA. Inorg Chem; 2023 Dec 25; 62(51):21181-21200. PubMed ID: 38079387 [Abstract] [Full Text] [Related]
6. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands. Sanz-Villafruela J, Bermejo-Casadesus C, Zafon E, Martínez-Alonso M, Durá G, Heras A, Soriano-Díaz I, Giussani A, Ortí E, Tebar F, Espino G, Massaguer A. Eur J Med Chem; 2024 Oct 05; 276():116618. PubMed ID: 38972079 [Abstract] [Full Text] [Related]
7. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity. Li S, Zhao J, Wang X, Xu G, Gou S, Zhao Q. Inorg Chem; 2020 Aug 03; 59(15):11193-11204. PubMed ID: 32702972 [Abstract] [Full Text] [Related]
8. Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (3IL) Excited States. Lifshits LM, Roque JA, Ramasamy E, Thummel RP, Cameron CG, McFarland SA. J Photochem Photobiol; 2021 Dec 03; 8():. PubMed ID: 35419549 [Abstract] [Full Text] [Related]
9. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents. Wang L, Yin H, Cui P, Hetu M, Wang C, Monro S, Schaller RD, Cameron CG, Liu B, Kilina S, McFarland SA, Sun W. Dalton Trans; 2017 Jun 27; 46(25):8091-8103. PubMed ID: 28604869 [Abstract] [Full Text] [Related]
10. Dinuclear Tridentate Ru(II) Complex with Strong Near-Infrared Light-Triggered Anticancer Activity. Wei L, Kushwaha R, Sadhukhan T, Wu H, Dao A, Zhang Z, Zhu H, Gong Q, Ru J, Liang C, Zhang P, Banerjee S, Huang H. J Med Chem; 2024 Jul 11; 67(13):11125-11137. PubMed ID: 38905437 [Abstract] [Full Text] [Related]
11. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells. Lin M, Zou S, Liao X, Chen Y, Luo D, Ji L, Chao H. Chem Commun (Camb); 2021 May 04; 57(36):4408-4411. PubMed ID: 33949487 [Abstract] [Full Text] [Related]
12. Bombesin-Targeted Delivery of β-Carboline-Based Ir(III) and Ru(II) Photosensitizers for a Selective Photodynamic Therapy of Prostate Cancer. Sanz-Villafruela J, Bermejo-Casadesús C, Riesco-Llach G, Iglesias M, Martínez-Alonso M, Planas M, Feliu L, Espino G, Massaguer A. Inorg Chem; 2024 Oct 14; 63(41):19140-19155. PubMed ID: 39361042 [Abstract] [Full Text] [Related]
13. A Multi-action and Multi-target RuII -PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers. Karges J, Yempala T, Tharaud M, Gibson D, Gasser G. Angew Chem Int Ed Engl; 2020 Apr 27; 59(18):7069-7075. PubMed ID: 32017379 [Abstract] [Full Text] [Related]
14. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy. Heinemann F, Karges J, Gasser G. Acc Chem Res; 2017 Nov 21; 50(11):2727-2736. PubMed ID: 29058879 [Abstract] [Full Text] [Related]
15. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers. Mo J, Mai Le NP, Priefer R. Eur J Med Chem; 2021 Dec 05; 225():113770. PubMed ID: 34403979 [Abstract] [Full Text] [Related]
16. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia. Liu X, Li G, Xie M, Guo S, Zhao W, Li F, Liu S, Zhao Q. Dalton Trans; 2020 Aug 18; 49(32):11192-11200. PubMed ID: 32748922 [Abstract] [Full Text] [Related]
17. Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia. Roque Iii JA, Cole HD, Barrett PC, Lifshits LM, Hodges RO, Kim S, Deep G, Francés-Monerris A, Alberto ME, Cameron CG, McFarland SA. J Am Chem Soc; 2022 May 11; 144(18):8317-8336. PubMed ID: 35482975 [Abstract] [Full Text] [Related]
20. Bithiophene-Functionalized Infrared Two-Photon Absorption Metal Complexes as Single-Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy. Li XL, Wang MF, Zeng LZ, Li GK, Zhao RY, Liu FD, Li Y, Yan YF, Liu Q, Li Z, Zhang H, Ren X, Gao F. Angew Chem Int Ed Engl; 2024 Jul 01; 63(27):e202402028. PubMed ID: 38656658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]